特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969683

がん治療薬 (抗がん剤) の世界市場 - 機会と戦略:COVID-19による影響と回復

Oncology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 442 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
がん治療薬 (抗がん剤) の世界市場 - 機会と戦略:COVID-19による影響と回復
出版日: 2020年11月10日
発行: The Business Research Company
ページ情報: 英文 442 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のがん治療薬 (抗がん剤) 市場について調査分析し、市場の特徴、市場規模と成長率、市場セグメンテーション、地域別・国別の内訳、競合情勢、市場シェア、動向と戦略について、体系的な情報を提供しています。

目次

第1章 がん治療薬 (抗がん剤) 市場のエグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

第7章 がん治療薬 (抗がん剤) 市場の特徴

第8章 がん治療薬 (抗がん剤) 市場のサプライチェーン分析

第9章 がん治療薬 (抗がん剤) 市場の製品分析:製品例

第10章 がん治療薬 (抗がん剤) 市場の顧客情報

第11章 がん治療薬 (抗がん剤) 市場の動向と戦略

第12章 主要ながん治療薬 (抗がん剤) 療法

  • 化学療法
  • 標的療法
  • 免疫療法(生物学的療法)
  • ホルモン療法
  • 放射線療法

第13章 腫瘍学における遺伝子治療

第14章 がん治療薬 (抗がん剤) のアンメットニーズ

第15章 パイプラインのがん治療薬 (抗がん剤)

第16章 世界のがん治療薬 (抗がん剤) 市場におけるトップ10の医薬品

第17章 がん治療薬 (抗がん剤) 市場に対するCOVID-19の影響

第18章 世界のがん治療薬 (抗がん剤) 市場規模と成長率

  • 市場規模
  • 市場成長実績 (金額)
  • 市場成長予測 (金額)

第19章 がん治療薬 (抗がん剤) 市場:地域別分析

  • 世界のがん治療薬 (抗がん剤) 市場:地域別、実績と予測 (金額別)
  • 世界のがん治療薬 (抗がん剤) 市場の実績と予測:地域別
  • 世界のがん治療薬 (抗がん剤) 市場の成長率と市場シェアの比較:地域別

第20章 世界のがん治療薬 (抗がん剤) 市場セグメンテーション

  • 世界のがん治療薬 (抗がん剤) 市場:タイプ別、実績と予測 (金額)
    • 血液がん
    • 乳がん
    • 肺がん
    • 前立腺がん
    • 結腸直腸がん
    • 子宮頸がん
    • 腎臓がん
    • 胃がん
    • 脳腫瘍
    • 皮膚ガン
    • 卵巣がん
    • 膀胱がん
    • 膵臓がん
    • 甲状腺がん
    • その他
  • 世界のがん治療薬 (抗がん剤) 市場:薬剤分類別、実績と予測 (金額)
    • 標的療法
    • 免疫療法(生物学的療法)
    • 化学療法
    • ホルモン療法
  • 世界のがん治療薬 (抗がん剤) 市場:投与経路別、実績と予測 (金額)
    • 非経口
    • 経口
    • その他
  • 世界のがん治療薬 (抗がん剤) 市場:流通チャネル別、実績と予測 (金額)
    • 病院薬局
    • 小売薬局/ドラッグストア
    • その他
  • 世界のがん治療薬 (抗がん剤) 市場:医薬品分類別、実績と予測 (金額)
    • ブランド
    • ジェネリック

第21章 世界のがん治療薬 (抗がん剤) 市場のマクロ経済的要因との比較

第22章 世界のがん治療薬 (抗がん剤) 市場の指標

第23章 アジア太平洋地域のがん治療薬 (抗がん剤) 市場

第24章 西欧のがん治療薬 (抗がん剤) 市場

第25章 東欧のがん治療薬 (抗がん剤) 市場

第26章 北米のがん治療薬 (抗がん剤) 市場

第27章 南米のがん治療薬 (抗がん剤) 市場

第28章 中東のがん治療薬 (抗がん剤) 市場

第29章 アフリカのがん治療薬 (抗がん剤) 市場

第30章 世界のがん治療薬 (抗がん剤) 市場の競合情勢

  • 企業プロファイル
  • F.Hoffmann-La Roche AG
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Johnson & Johnson

第31章 がん治療薬 (抗がん剤) 市場における主要なM&A

第32章 市場の背景:医薬品市場

第33章 がん治療薬 (抗がん剤) 市場の機会と戦略

第34章 がん治療薬 (抗がん剤) 市場の結論・提言

第35章 付録

目次

“Oncology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology drugs market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the oncology drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The global oncology drugs global market opportunities and strategies to 2030: COVID 19 impact and recovery report ”from the Business Research Company answers all these questions and many more.

The report covers the following chapters

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by distribution channel, by route of administration and by drug classification.
  • Market Characteristics - The market characteristics section of the report defines and explains the oncology drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the oncology drugs industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products in the oncology drugs market along with key features and differentiators for those products.
  • Customer Information - This chapter covers recent customers' trends/preferences in the global oncology drugs market.
  • Trends And Strategies - This chapter describes the major trends shaping the global oncology drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Oncology Drug Therapies - This section describes the major therapies in the market to effectively treat different cancer types.
  • Gene Therapy - This chapter describes the different futuristic gene therapies to treat or prevent the spread of cancer.
  • Unmet Needs In Oncology Drugs - This chapter describes the several unmet needs in the oncology drugs market which are expected to reach the market in the future.
  • Drugs In Pipeline - This section covers list of latest drugs in pipeline and their description.
  • Top Oncology Drugs - This section provides information of the top 10 drugs that are used to treat cancer by the revenue generated and company that has developed the drug.
  • Impact of CoVID-19 - This section describes the impact of COVID-19 on the oncology drugs market.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
  • Global Macro Comparison - The global oncology drugs market comparison with macro-economic factors gives the oncology drugs market size, percentage of GDP, and average oncology drugs market expenditure.
  • Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global oncology drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the pharmaceutical drugs market of which the oncology drugs market is a segment. This chapter includes the global pharmaceutical drugs market 2015-19 and 2019-23 values, and regional and country analyses for the pharmaceutical drugs market.
  • Opportunities And Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for oncology drug manufacturers in terms of product offerings, geographic expansion, price offerings, and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

The global oncology drugs market is segmented into -

  • By Type Of Drug: Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others
  • By Drug Class: Targeted Therapy; Immunotherapy (Biologic Therapy); Chemotherapy; Hormonal Therapy
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
  • By Route Of Administration: Oral; Parental; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • Companies Mentioned: Novartis AG; Bristol-Myers Squibb Company; Merck & Co., Inc.; Johnson & Johnson; Pfizer Inc.
  • Countries: China, Australia, Hong Kong, India, Indonesia, Japan, Malaysia , New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Czech Republic, Poland, Romania, Russia, Canada, Mexico, USA, Argentina, Brazil , Chile, Colombia, Peru, Venezuela, Saudi Arabia, Israel, Turkey, UAE, Egypt, Nigeria, South Africa
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series:: It covers one five years' period, two four years' period and one six years' period including, 2015 to 2019, termed the historic period, and 2019 to 2023 forecast period, 2023 - 2025 forecast period and 2025 -2030 the forecast period.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Oncology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Type
    • 6.1.3. Segmentation By Drug Class Type
    • 6.1.4. Segmentation By Distribution Channel
    • 6.1.5. Segmentation By Route Of Administration
    • 6.1.6. Segmentation By Drug Classification

7. Oncology Drugs Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Type
    • 7.2.1. Lung Cancer Drugs
    • 7.2.2. Pancreatic Cancer Drugs
    • 7.2.3. Breast Cancer Drugs
    • 7.2.4. Prostate Cancer Drugs
    • 7.2.5. Ovarian Cancer Drugs
    • 7.2.6. Colorectal Cancer Drugs
    • 7.2.7. Gastric Cancer Drugs
    • 7.2.8. Kidney Cancer Drugs
    • 7.2.9. Brain Tumor Drugs
    • 7.2.10. Thyroid Cancer Drugs
    • 7.2.11. Skin Cancer Drugs
    • 7.2.12. Bladder Cancer Drugs
    • 7.2.13. Cervical Cancer Drugs
    • 7.2.14. Blood Cancer Drugs
    • 7.2.15. Others
  • 7.3. Market Segmentation By Drug Class Type
    • 7.3.1. Chemotherapy
    • 7.3.2. Targeted Therapy
    • 7.3.3. Immunotherapy (Biologic Therapy)
    • 7.3.4. Hormonal Therapy
  • 7.4. Market Segmentation By Distribution Channel
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies/Drug Stores
    • 7.4.3. Other Pharmacies
  • 7.5. Market Segmentation By Route Of Administration
    • 7.5.1. Oral
    • 7.5.2. Parenteral
    • 7.5.3. Others
  • 7.6. Market Segmentation By Drug Classification
    • 7.6.1. Branded Drugs
    • 7.6.2. Generic Drugs

8. Oncology Drugs Market, Supply Chain Analysis

  • 8.1. Raw Material Suppliers
  • 8.2. Contract Research Organization (CRO)
  • 8.3. Oncology Drugs Manufacturer
    • 8.3.1. Drug Discovery
    • 8.3.2. Preclinical And Clinical Trials
    • 8.3.3. Patents Upon Discovery And Approval
    • 8.3.4. Drug Manufacturing
  • 8.4. Contract Manufacturing Organization (CMO)
  • 8.5. Wholesalers/Distributors
  • 8.6. Retailers (Pharmacies) And Hospitals
  • 8.7. Oncologists
  • 8.8. End-Users

9. Oncology Drugs Market, Product Analysis - Product Examples

10. Oncology Drugs Market Customer Information

  • 10.1. Cancer Patients Need More Knowledge On Their Treatment
  • 10.2. COVID-19 Pandemic Effects On Cancer Patients and Survivors
  • 10.3. Pharma Salespeople Are A Major Influence On Oncologists
  • 10.4. Only 17% Of Cancer Patients Are Treated Right
  • 10.5. Major Challenges To Future Cancer Program Growth
  • 10.6. Americans Taking More Prescription Drugs than Ever
  • 10.7. Dutch Patients Highly Satisfied With Information On Chemotherapy

11. Oncology Drugs Market Trends And Strategies

  • 11.1. Development And Increasing Demand For Next Generation Biologics
  • 11.2. Innovation in Patient Therapies (New Active Substances)
  • 11.3. CRISPR-Cas9 Technology Use In Cancer Treatment
  • 11.4. Expansion Of Cell And Gene Therapy & CAR-T Approvals
  • 11.5. Microneedle Pills
  • 11.6. Development Of Personalized Cancer Vaccines
  • 11.7. Rising Focus On Immunotherapy Drugs For Cancer Treatment
  • 11.8. Development Of New Drugs To Treat Blood Cancer
  • 11.9. Collaboration Driving Innovation
  • 11.10. Investment In Artificial Intelligence For Oncology Drugs
  • 11.11. Use Of 3D Printing To Test New Oncology Drugs
  • 11.12. Rising Focus On Targeted Therapy
  • 11.13. Shift Towards Oral Chemotherapy Drugs

12. Leading Oncology Drug Therapies

  • 12.1. Chemotherapy
  • 12.2. Targeted Therapy
  • 12.3. Immunotherapy (Biologic Therapy)
  • 12.4. Hormonal Therapy
  • 12.5. Radiation Therapy

13. Gene Therapy In Oncology

  • 13.1. Artificial Cell Stimulation
  • 13.2. Oncolytic Virotherapy
  • 13.3. Gene Transfer
  • 13.4. Others

14. Unmet Needs In Oncology Drugs

  • 14.1. Novel Mechanism Of Action
  • 14.2. Less Treatment Options Available For Rare Cancers
  • 14.3. Unfavorable Benefits/Risk
  • 14.4. Intractable Tumors
  • 14.5. Intractable Tumors Subsets
  • 14.6. Rare Or Unclassifiable Tumors

15. Oncology Drugs In Pipeline

16. Top 10 Drugs In The Global Oncology drugs Market

17. COVID Impact On The Oncology Drugs Market

  • 17.1. Clinical Trial Delays
  • 17.2. Low Usage Of Drugs
  • 17.3. Supply Chain Issues

18. Global Oncology Drugs Market Size And Growth

  • 18.1. Market Size
  • 18.2. Historic Market Growth, 2015 - 2019, Value ($ Billion)
    • 18.2.1. Drivers Of The Market 2015 - 2019
    • 18.2.2. Restraints On The Market 2015 - 2019
  • 18.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
    • 18.3.1. Drivers Of The Market 2019 - 2023
    • 18.3.2. Restraints On The Market 2019 - 2023

19. Oncology Drugs Market, Regional Analysis

  • 19.1. Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 19.2. Global Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Region
  • 19.3. Global Oncology Drugs Market, 2019-2023, Growth And Market Share Comparison, By Region

20. Global Oncology Drugs Market Segmentation

  • 20.1. Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 20.1.1. Blood Cancer
    • 20.1.2. Breast Cancer
    • 20.1.3. Lung Cancer
    • 20.1.4. Prostate cancer
    • 20.1.5. Colorectal Cancer
    • 20.1.6. Cervical Cancer
    • 20.1.7. Kidney Cancer
    • 20.1.8. Gastric Cancer
    • 20.1.9. Brain Tumor
    • 20.1.10. Skin Cancer
    • 20.1.11. Ovarian Cancer
    • 20.1.12. Bladder Cancer
    • 20.1.13. Pancreatic Cancer
    • 20.1.14. Thyroid Cancer
    • 20.1.15. Others
  • 20.2. Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 20.2.1. Targeted Therapy drugs
    • 20.2.2. Immunotherapy (Biologic Therapy) drugs
    • 20.2.3. Chemotherapy drugs
    • 20.2.4. Hormonal Therapy drugs
  • 20.3. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 20.3.1. Parenteral route of administration
    • 20.3.2. Oral route of administration
    • 20.3.3. Others route of administration
  • 20.4. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 20.4.1. Hospital Pharmacies distribution channel
    • 20.4.2. Retail Pharmacies/Drug Stores distribution channel
    • 20.4.3. Others distribution channel
  • 20.5. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 20.5.1. Branded
    • 20.5.2. Generic

21. Global Oncology Drugs Market Comparison with Macro Economic Factors

  • 21.1. Oncology Drugs Market Size, Percentage Of GDP, Global
  • 21.2. Per Capita Average Oncology Drugs Market Expenditure, Global

22. Global Oncology Drugs Market Metrics

  • 22.1. Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Country
  • 22.2. Estimated Average Expenditure, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence, 2019, By Region

23. Asia-Pacific Oncology Drugs Market

  • 23.1. Asia-Pacific Oncology Drugs Market Overview
    • 23.1.1. Region Information
    • 23.1.2. COVID Impact
    • 23.1.3. Market Information
    • 23.1.4. Background Information
    • 23.1.5. New Drug Approvals
    • 23.1.6. Government Initiatives
    • 23.1.7. Regulations
    • 23.1.8. Regulatory Bodies
    • 23.1.9. Major Associations
    • 23.1.10. Taxes Levied
    • 23.1.11. Corporate Tax Structure
    • 23.1.12. Investment
    • 23.1.13. Major Companies
  • 23.2. Asia-Pacific Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.3. Asia-Pacific Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.4. Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.5. Asia-Pacific Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 23.6. Asia-Pacific Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 23.7. Asia-Pacific Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 23.8. Asia-Pacific Oncology Drugs Market Metrics
    • 23.8.1. Per Capita Oncology Drugs Expenditure, 2019, Asia-Pacific Major Countries
  • 23.9. Asia-Pacific Oncology Drugs Market: Country Analysis
  • 23.10. Australia Oncology Drugs Market
  • 23.11. Australia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.12. Australia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.13. Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.14. China Oncology Drugs Market
  • 23.15. China Oncology Drugs Market Overview
    • 23.15.1. Country Information
    • 23.15.2. COVID Impact
    • 23.15.3. Market Information
    • 23.15.4. Background Information
    • 23.15.5. New Drug Approvals
    • 23.15.6. Government Initiatives
    • 23.15.7. Regulations
    • 23.15.8. Regulatory Bodies
    • 23.15.9. Major Associations
    • 23.15.10. Taxes Levied
    • 23.15.11. Corporate Tax Structure
    • 23.15.12. Investment
    • 23.15.13. Major Companies
  • 23.16. China Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.17. China Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.18. China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.19. Hong Kong Oncology Drugs Market
  • 23.20. Hong Kong Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.21. Hong Kong Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.22. India Oncology Drugs Market
  • 23.23. India Oncology Drugs Market Overview
    • 23.23.1. Country Information
    • 23.23.2. COVID Impact
    • 23.23.3. Market Information
    • 23.23.4. Background Information
    • 23.23.5. New Drug Approvals
    • 23.23.6. Government Initiatives
    • 23.23.7. Regulations
    • 23.23.8. Regulatory Bodies
    • 23.23.9. Major Associations
    • 23.23.10. Taxes Levied
    • 23.23.11. Corporate Tax Structure
    • 23.23.12. Investments
    • 23.23.13. Major Companies
  • 23.24. India Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.25. India Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.26. India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.27. Indonesia Oncology Drugs Market
  • 23.28. Indonesia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.29. Indonesia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.30. Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.31. Japan Oncology Drugs Market
  • 23.32. Japan Oncology Drugs Market Overview
    • 23.32.1. Region Information
    • 23.32.2. COVID Impact
    • 23.32.3. Market Information
    • 23.32.4. Background Information
    • 23.32.5. New Drug Approvals
    • 23.32.6. Government Initiatives
    • 23.32.7. Regulations
    • 23.32.8. Regulatory Bodies
    • 23.32.9. Major Associations
    • 23.32.10. Taxes Levied
    • 23.32.11. Corporate Tax Structure
    • 23.32.12. Investments
    • 23.32.13. Major Companies
  • 23.33. Japan Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.34. Japan Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.35. Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.36. Malaysia Oncology Drugs Market
  • 23.37. Malaysia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.38. Malaysia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.39. New Zealand Oncology Drugs Market
  • 23.40. New Zealand Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.41. New Zealand Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.42. Philippines Oncology Drugs Market
  • 23.43. Philippines Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.44. Philippines Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.45. Singapore Oncology Drugs Market
  • 23.46. Singapore Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.47. Singapore Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.48. South Korea Oncology Drugs Market
  • 23.49. South Korea Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.50. South Korea Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.51. South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 23.52. Thailand Oncology Drugs Market
  • 23.53. Thailand Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.54. Thailand Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 23.55. Vietnam Oncology Drugs Market
  • 23.56. Vietnam Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 23.57. Vietnam Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)

24. Western Europe Oncology Drugs Market

  • 24.1. Western Europe Oncology Drugs Market Overview
    • 24.1.1. Region Information
    • 24.1.2. COVID Impact
    • 24.1.3. Market Information
    • 24.1.4. Background Information
    • 24.1.5. New Drug Approvals
    • 24.1.6. Government Initiatives
    • 24.1.7. Regulations
    • 24.1.8. Regulatory Bodies
    • 24.1.9. Major Associations
    • 24.1.10. Taxes Levied
    • 24.1.11. Corporate Tax Structure
    • 24.1.12. Investment
    • 24.1.13. Major Companies
  • 24.2. Western Europe Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.3. Western Europe Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.4. Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 24.5. Western Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 24.6. Western Europe Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 24.7. Western Europe Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 24.8. Western Europe Oncology Drugs Market Metrics
    • 24.8.1. Per Capita Oncology Drugs Expenditure, 2019, Western Europe Major Countries
  • 24.9. Western Europe Oncology Drugs Market: Country Analysis
  • 24.10. Austria Oncology Drugs Market
  • 24.11. Austria Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.12. Austria Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.13. Belgium Oncology Drugs Market
  • 24.14. Belgium Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.15. Belgium Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.16. Denmark Oncology Drugs Market
  • 24.17. Denmark Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.18. Denmark Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.19. Finland Oncology Drugs Market
  • 24.20. Finland Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.21. Finland Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.22. France Oncology Drugs Market
  • 24.23. France Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.24. France Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.25. France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 24.26. Germany Oncology Drugs Market
  • 24.27. Germany Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.28. Germany Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.29. Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 24.30. Ireland Oncology Drugs Market
  • 24.31. Ireland Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.32. Ireland Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.33. Italy Oncology Drugs Market
  • 24.34. Italy Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.35. Italy Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.36. Netherlands Oncology Drugs Market
  • 24.37. Netherlands Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.38. Netherlands Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.39. Norway Oncology Drugs Market
  • 24.40. Norway Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.41. Norway Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.42. Portugal Oncology Drugs Market
  • 24.43. Portugal Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.44. Portugal Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.45. Spain Oncology Drugs Market
  • 24.46. Spain Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.47. Spain Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.48. Sweden Oncology Drugs Market
  • 24.49. Sweden Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.50. Sweden Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.51. Switzerland Oncology Drugs Market
  • 24.52. Switzerland Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.53. Switzerland Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.54. UK Oncology Drugs Market
  • 24.55. UK Oncology Drugs Market Overview
    • 24.55.1. Country Information
    • 24.55.2. COVID Impact
    • 24.55.3. Market Information
    • 24.55.4. Background Information
    • 24.55.5. New Drug Approvals
    • 24.55.6. Government Initiatives
    • 24.55.7. Regulations
    • 24.55.8. Regulatory Bodies
    • 24.55.9. Major Associations
    • 24.55.10. Taxes Levied
    • 24.55.11. Corporate Tax Structure
    • 24.55.12. Investments
    • 24.55.13. Major Companies
  • 24.56. UK Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 24.57. UK Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 24.58. UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)

25. Eastern Europe Oncology Drugs Market

  • 25.1. Eastern Europe Oncology Drugs Market Overview
    • 25.1.1. Region Information
    • 25.1.2. Impact Of COVID-19
    • 25.1.3. Market Information
    • 25.1.4. Background Information
    • 25.1.5. New Drug Approvals
    • 25.1.6. Government Initiatives
    • 25.1.7. Regulations
    • 25.1.8. Regulatory Bodies
    • 25.1.9. Major Associations
    • 25.1.10. Taxes Levied
    • 25.1.11. Corporate Tax Structure
    • 25.1.12. Investments
    • 25.1.13. Major Companies
  • 25.2. Eastern Europe Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 25.3. Eastern Europe Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 25.4. Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 25.5. Eastern Europe Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 25.6. Eastern Europe Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 25.7. Eastern Europe Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 25.8. Eastern Europe Oncology Drugs Market Metrics
    • 25.8.1. Per Capita Oncology Drugs Expenditure, 2019, Eastern Europe Major Countries
  • 25.9. Eastern Europe Oncology Drugs Market: Country Analysis
  • 25.10. Czech Republic Oncology Drugs Market
  • 25.11. Czech Republic Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 25.12. Czech Republic Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 25.13. Poland Oncology Drugs Market
  • 25.14. Poland Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 25.15. Poland Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 25.16. Romania Oncology Drugs Market
  • 25.17. Romania Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 25.18. Romania Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 25.19. Russia Oncology Drugs Market
  • 25.20. Russia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 25.21. Russia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 25.22. Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)

26. North America Oncology Drugs Market

  • 26.1. North America Oncology Drugs Market Overview
    • 26.1.1. Region Information
    • 26.1.2. Impact Of COVID-19
    • 26.1.3. Market Information
    • 26.1.4. Background Information
    • 26.1.5. New Drug Approvals
    • 26.1.6. Government Initiatives
    • 26.1.7. Regulations
    • 26.1.8. Regulatory Bodies
    • 26.1.9. Major Associations
    • 26.1.10. Taxes Levied
    • 26.1.11. Corporate Tax Structure
    • 26.1.12. Investments
    • 26.1.13. Major Companies
  • 26.2. North America Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 26.3. North America Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 26.4. North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 26.5. North America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 26.6. North America Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 26.7. North America Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 26.8. North America Oncology Drugs Market Metrics
    • 26.8.1. Per Capita Oncology Drugs Expenditure, 2019, North America Major Countries
  • 26.9. North America Oncology Drugs Market: Country Analysis
  • 26.10. Canada Oncology Drugs Market
  • 26.11. Canada Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 26.12. Canada Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 26.13. Mexico Oncology Drugs Market
  • 26.14. Mexico Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 26.15. Mexico Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 26.16. USA Oncology Drugs Market
  • 26.17. USA Oncology Drugs Market Overview
    • 26.17.1. Country Information
    • 26.17.2. Impact Of COVID-19
    • 26.17.3. Market Information
    • 26.17.4. Background Information
    • 26.17.5. New Drug Approvals
    • 26.17.6. Government Initiatives
    • 26.17.7. Regulations
    • 26.17.8. Regulatory Bodies
    • 26.17.9. Major Associations
    • 26.17.10. Corporate Tax Structure
    • 26.17.11. Investments
    • 26.17.12. Major Companies
  • 26.18. USA Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 26.19. USA Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 26.20. USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)

27. South America Oncology Drugs Market

  • 27.1. South America Oncology Drugs Market Overview
    • 27.1.1. Region Information
    • 27.1.2. COVID Impact
    • 27.1.3. Market Information
    • 27.1.4. Background Information
    • 27.1.5. New Drug Approvals
    • 27.1.6. Government Initiatives
    • 27.1.7. Regulations
    • 27.1.8. Regulatory Bodies
    • 27.1.9. Major Associations
    • 27.1.10. Taxes Levied
    • 27.1.11. Corporate Tax Structure
    • 27.1.12. Investments
    • 27.1.13. Major Companies
  • 27.2. South America Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.3. South America Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.4. South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 27.5. South America Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 27.6. South America Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 27.7. South America Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 27.8. South America Oncology Drugs Market Metrics
    • 27.8.1. Per Capita Oncology Drugs Expenditure, 2019, South America Major Countries
  • 27.9. South America Oncology Drugs Market: Country Analysis
  • 27.10. Argentina Oncology Drugs Market
  • 27.11. Argentina Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.12. Argentina Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.13. Brazil Oncology Drugs Market
  • 27.14. Brazil Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.15. Brazil Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.16. Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 27.17. Chile Oncology Drugs Market
  • 27.18. Chile Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.19. Chile Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.20. Colombia Oncology Drugs Market
  • 27.21. Colombia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.22. Colombia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.23. Peru Oncology Drugs Market
  • 27.24. Peru Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.25. Peru Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 27.26. Venezuela Oncology Drugs Market
  • 27.27. Venezuela Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 27.28. Venezuela Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)

28. Middle East Oncology Drugs Market

  • 28.1. Middle East Oncology Drugs Market Overview
    • 28.1.1. Region Information
    • 28.1.2. Impact Of COVID-19
    • 28.1.3. Market Information
    • 28.1.4. Background Information
    • 28.1.5. New Drug Approvals
    • 28.1.6. Government Initiatives
    • 28.1.7. Regulations
    • 28.1.8. Regulatory Bodies
    • 28.1.9. Major Associations
    • 28.1.10. Taxes Levied
    • 28.1.11. Corporate Tax Structure
    • 28.1.12. Investments
    • 28.1.13. Major Companies
  • 28.2. Middle East Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 28.3. Middle East Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 28.4. Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 28.5. Middle East Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 28.6. Middle East Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 28.7. Middle East Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 28.8. Middle East Oncology Drugs Market Metrics
    • 28.8.1. Per Capita Oncology Drugs Expenditure, 2019, Middle East Major Countries
  • 28.9. Middle East Oncology Drugs Market: Country Analysis
  • 28.10. Israel Oncology Drugs Market
  • 28.11. Israel Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 28.12. Israel Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 28.13. Saudi Arabia Oncology Drugs Market
  • 28.14. Saudi Arabia Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 28.15. Saudi Arabia Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 28.16. Turkey Oncology Drugs Market
  • 28.17. Turkey Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 28.18. Turkey Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 28.19. UAE Oncology Drugs Market
  • 28.20. UAE Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 28.21. UAE Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)

29. Africa Oncology Drugs Market

  • 29.1. Africa Oncology Drugs Market Overview
    • 29.1.1. Region Information
    • 29.1.2. Impact Of COVID-19
    • 29.1.3. Market Information
    • 29.1.4. Background Information
    • 29.1.5. Government Initiatives
    • 29.1.6. Regulations
    • 29.1.7. Regulatory Bodies
    • 29.1.8. Major Associations
    • 29.1.9. Taxes Levied
    • 29.1.10. Corporate Tax Structure
    • 29.1.11. Investments
    • 29.1.12. Major Companies
  • 29.2. Africa Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 29.3. Africa Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 29.4. Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 29.5. Africa Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • 29.6. Africa Oncology Drugs Market, 2015 - 2023, Historic And Forecast, By Country
  • 29.7. Africa Oncology Drugs Market, 2019 - 2023, Growth And Market Share Comparison, By Country
  • 29.8. Africa Oncology Drugs Market Metrics
    • 29.8.1. Per Capita Oncology Drugs Expenditure, 2019, Africa Major Countries
  • 29.9. Africa Oncology Drugs Market: Country Analysis
  • 29.10. Egypt Oncology Drugs Market
  • 29.11. Egypt Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 29.12. Egypt Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 29.13. Nigeria Oncology Drugs Market
  • 29.14. Nigeria Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 29.15. Nigeria Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)
  • 29.16. South Africa Oncology Drugs Market
  • 29.17. South Africa Oncology Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Billion)
  • 29.18. South Africa Oncology Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Billion)

30. Global Oncology Drugs Market Competitive Landscape

  • 30.1. Company Profiles
  • 30.2. F.Hoffmann-La Roche AG
    • 30.2.1. Company Overview
    • 30.2.2. Products And Services
    • 30.2.3. Business Strategy
    • 30.2.4. Financial Overview
  • 30.3. Novartis AG
    • 30.3.1. Company Overview
    • 30.3.2. Products And Services
    • 30.3.3. Business Strategy
    • 30.3.4. Financial Overview
  • 30.4. Bristol-Myers Squibb Company
    • 30.4.1. Company Overview
    • 30.4.2. Products And Services
    • 30.4.3. Business Strategy
    • 30.4.4. Financial overview
  • 30.5. Merck & Co., Inc.
    • 30.5.1. Company Overview
    • 30.5.2. Products And Services
    • 30.5.3. Business Strategy
    • 30.5.4. Financial Overview
  • 30.6. Johnson & Johnson
    • 30.6.1. Company Overview
    • 30.6.2. Products And Services
    • 30.6.3. Business Strategy
    • 30.6.4. Financial Overview

31. Key Mergers And Acquisitions In The Oncology Drugs Market

  • 31.1. Gilead Sciences, Inc.Acquired 49.9% Equity In Pionyr Immunotherapeutics Inc.
  • 31.2. Mediolanum Farmaceutici Acquired ElsaLys Biotech
  • 31.3. True North Acquired Minority Stake In Biocon Biologics Ltd.
  • 31.4. PAG Acquired Stake In Hisun BioRay
  • 31.5. Eli Lilly And Company Acquired Loxo Oncology, Inc.
  • 31.6. Fuji Pharma Co., Ltd.Acquired Stake In Alvotech
  • 31.7. Bristol-Myers Squibb Acquired Celgene Corporation
  • 31.8. Kashiv Pharma, LLC Acquired Adello Biologics
  • 31.9. Takeda Pharmaceutical Company Limited Acquired Shire Plc
  • 31.10. GlaxoSmithKline Plc Acquired Tesaro, Inc.
  • 31.11. Mundipharma International Limited Acquired Cinfa Biotech
  • 31.12. F.Hoffmann-La Roche AG Acquired Tusk Therapeutics Ltd
  • 31.13. Eli Lilly And Company Acquired ARMO BioSciences, Inc.
  • 31.14. Threshold Pharmaceuticals Merged With Molecular Templates, Inc.
  • 31.15. Ipsen Acquired Oncology Assets From Merrimack Pharmaceuticals
  • 31.16. Takeda Pharmaceutical Company Limited Acquired ARIAD Pharmaceuticals, Inc.
  • 31.17. Sumitomo Dainippon Pharma Co., Ltd.Acquired Tolero Pharmaceuticals, Inc.
  • 31.18. Astellas Pharma Inc.Acquired GANYMED Pharmaceuticals AG

32. Market Background: Pharmaceutical Drugs Market

  • 32.1. Pharmaceutical Drugs Market Characteristics
    • 32.1.1. Market Definition
    • 32.1.2. Segmentation By Type
  • 32.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 - 2023, Value ($ Billion)
  • 32.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 32.4. Global Pharmaceutical Drugs Market, 2015 - 2023, Historic And Forecast, By Region

33. Oncology Drugs Market Opportunities & Strategies

  • 33.1. Global Oncology Drugs Market In 2023 - Countries Offering Most New Opportunities
  • 33.2. Global Oncology Drugs Market In 2023 - Segments Offering Most New Opportunities
  • 33.3. Global Oncology Drugs Market In 2023 - Growth Strategies
    • 33.3.1. Market Trend Based Strategies
    • 33.3.2. Competitor Strategies

34. Oncology Drugs Market, Conclusions And Recommendations

  • 34.1. Conclusions
  • 34.2. Recommendations
    • 34.2.1. Product
    • 34.2.2. Price
    • 34.2.3. Place
    • 34.2.4. Promotion

35. Appendix

  • 35.1. Market Data Sources
  • 35.2. NAICS Definitions Of Industry Covered In This Report
  • 35.3. Research Methodology
  • 35.4. Currencies
  • 35.5. Research Inquiries
  • 35.6. The Business Research Company
  • 35.7. Copyright and Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.